Ilaria Bove

Dr. Ilaria Bove


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2023 in Brain and Spine
Verified
Journal Article
Open access
IBIlaria Bove
Ilaria Bove
Domenico SolariDomenico Solari
Domenico Solari
MBMichaël Bruneau
Michaël Bruneau
MBMoncef Berhouma
Moncef Berhouma
EJEmmanuel Jouanneau
Emmanuel Jouanneau
LCLuigi Maria Cavallo
Luigi Maria Cavallo
The use of an endoscope in skull base surgery provides a panoramic close-up view over the intracranial structures from multiple angles with excellent illumination, thus permitting greater extent of resection of tumors arising at sellar area, mostly represented by PitNet - Pituitary neuroendocrine tumors, with higher likelihood of preserving vital/intact gland tissue. For this refined specialty of neurosurgery, unique skills need to be acquired along a steep learning curve. EANS (European Association of Neurosurgical Societies) skull base section panelists were enrolled and 11 completed the survey: the goal was to provide a consensus statement of the endoscopic endonasal approach for pituitary adenoma surgery. The survey consisted of 44 questions covering demographics data (i.e., academic/non-academic center, case load, years of experience), surgical techniques (i.e., use of neuronavigation, preoperative imaging), and follow-up management. In this paper we identified a series of tips and tricks at different phases of an endoscopic endonasal pituitary surgery procedure to underline the crucial steps to perform successful surgery and reduce complications: we took in consideration the principles of the surgical technique, the knowledge of the anatomy and its variations, and finally the importance of adjoining specialties experts.

29 December 2022 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
TSTeresa Somma
Teresa Somma
IBIlaria Bove
Ilaria Bove
FVFrancesca Vitulli
Francesca Vitulli
PCPaolo Cappabianca
Paolo Cappabianca
FPFederico Pessina
Federico Pessina
DBDaniele Bongetta
Daniele Bongetta

7 December 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
GVGiovanni Vitale
Giovanni Vitale
GTGaetano Terrone
Gaetano Terrone
SVSamuel Vitale
Samuel Vitale
FVFrancesca Vitulli
Francesca Vitulli
SASalvatore Aiello
Salvatore Aiello
TWThomas Wiese
Thomas Wiese
Tuberous sclerosis complex (TSC) is a rare multisystem genetic disorder characterized by benign tumor growth in multiple organs, including the brain, kidneys, heart, eyes, lungs, and skin. Pathogenesis stems from mutations in either the TSC1 or TSC2 gene, which encode the proteins hamartin and tuberin, respectively. These proteins form a complex that inhibits the mTOR pathway, a critical regulator of cell growth and proliferation. Disruption of the tuberin–hamartin complex leads to overactivation of mTOR signaling and uncontrolled cell growth, resulting in hamartoma formation. Neurological manifestations are common in TSC, with epilepsy developing in up to 90% of patients. Seizures tend to be refractory to medical treatment with anti-seizure medications. Infantile spasms and focal seizures are the predominant seizure types, often arising in early childhood. Drug-resistant epilepsy contributes significantly to morbidity and mortality. This review provides a comprehensive overview of the current state of knowledge regarding the pathogenesis, clinical manifestations, and treatment approaches for epilepsy and other neurological features of TSC. While narrative reviews on TSC exist, this review uniquely synthesizes key advancements across the areas of TSC neuropathology, conventional and emerging pharmacological therapies, and targeted treatments. The review is narrative in nature, without any date restrictions, and summarizes the most relevant literature on the neurological aspects and management of TSC. By consolidating the current understanding of TSC neurobiology and evidence-based treatment strategies, this review provides an invaluable reference that highlights progress made while also emphasizing areas requiring further research to optimize care and outcomes for TSC patients.

16 September 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Domenico SolariDomenico Solari
Domenico Solari
LCLuigi Maria Cavallo
Luigi Maria Cavallo
CGChiara Graziadio
Chiara Graziadio
SCSergio Corvino
Sergio Corvino
IBIlaria Bove
Ilaria Bove
PCPaolo Cappabianca
Paolo Cappabianca
Giant pituitary adenomas are a subgroup of pituitary adenomas defined by a diameter greater than 4 cm, and they account for 5–14% of adenomas in surgical series. Because of their growth patterns and locations, often involving critical neurovascular structures, they represent a true surgical challenge, and gross total resection is difficult to achieve. There is no consensus on the optimal surgical strategy for giant pituitary adenomas, and, often, integrated multi-staged treatment strategies have been considered. Transcranial or transsphenoidal approaches, alone or combined, according to tumor and patient features are the two main routes. Each of these strategies has pros and cons. The conventional transcranial approach has for a long time been considered the first choice for the removal of giant pituitary adenomas. Currently, with endoscopic techniques, it is also possible to remove lesions that involve the intradural compartment and the adjacent neurovascular structures with the use of extended approaches. Our policy for the management of these lesions is to adopt the endoscopic endonasal approach as the first choice unless the tumor presents significant intracranial extension that results in it being outside the visibility and maneuverability of the endoscopic endonasal route. In these latter cases, we agree that the transcranial approach is more appropriate. However, accurate preoperative evaluation and refined treatment plans for each patient are mandatory to define a proper strategy in order to achieve the most effective long-term result.

24 January 2024 in Neurosurgical Review
Verified
Journal Article
Open access
PDF file
TSTeresa Somma
Teresa Somma
IBIlaria Bove
Ilaria Bove
FVFrancesca Vitulli
Francesca Vitulli
DSDomenico Solari
Domenico Solari
ABAndrea Bocchino
Andrea Bocchino
FEFelice Esposito
Felice Esposito
Subthalamic nucleus deep brain stimulation (STN-DBS) is an effective treatment of PD for both women and men. However, discussions have been reported about the impact of STN-DBS surgery in PD. The aim of our study is to identify differences between men and women in terms of pre- and post-DBS symptoms and try to explain the possible causes. In the current study, we evaluated the gender impact on STN-DBS in PD at the Department of Neurosurgery of University of Naples “Federico II” from 2013 to 2021. Motor and non-motor symptoms were evaluated. To compare the data before and after surgery and between the genders, Wilcoxon-Mann–Whitney tests were performed. A total of 43 patients with PD were included; of them, 17 (39%) were female. Baseline evaluation revealed no gender differences in the age of onset (p = 0.87). Not significant differences were noted in the Unified Parkinson’s Disease Rating Scale (UPDRS) pre-surgery score, but if we consider UPDRS subscores of motor examination, significant clinical improvement was reported in both male and female in terms of UPDRS pre- and post-surgery (p < 0.001). STN-DBS is a highly effective treatment for motor and non-motor symptoms of PD for both women and men but our study hints towards gender-specific outcomes in motor domains. Improving our knowledge in this field can allow us to implement strategies to identify new directions in the development of an adequate treatment of PD in terms of surgical intervention and in consideration of the gender.

11 August 2020 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
IBIlaria Bove
Ilaria Bove
IBIlaria Bove
Ilaria Bove
FEFelice Esposito
Felice Esposito
PCPaolo Cappabianca
Paolo Cappabianca
LCLuigi M. Cavallo
Luigi M. Cavallo